Q4 2025 Mckesson Corp Earnings Call Transcript
Key Points
- McKesson Corp (MCK) reported a 16% increase in full-year consolidated revenues, reaching a record $359 billion.
- Adjusted earnings per diluted share grew by 20%, surpassing long-term growth targets.
- The company returned $3.5 billion of cash to shareholders, demonstrating strong cash flow management.
- Strategic acquisitions in oncology and other specialties, such as PRISM Vision and Core Ventures, are expected to accelerate growth.
- The Prescription Technology Solutions segment experienced double-digit growth in adjusted operating profit, driven by strong demand for access and affordability solutions.
- The divestiture of Canadian businesses, including Rexall and Well.ca, resulted in lower contributions from the International segment.
- Operating expenses decreased by 10% due to divestitures and cost optimization, which may indicate potential downsizing or restructuring.
- The Medical Surgical segment experienced softer volumes in the primary care market, impacting growth.
- The company faces a dynamic market environment with uncertainties in policies and macroeconomic conditions.
- Free cash flow guidance for fiscal 2026 is lower than the previous year, reflecting potential cash outflows for acquisitions.
Welcome to McKesson's fourth quarter fiscal 2025 earnings conference call. Please be advised that today's conference is being recorded.
At this time, I'd like to turn the call over to Jeni Dominguez, VP of Investor Relations. Please go ahead.
Good afternoon, and welcome, everyone, to McKesson's fourth quarter fiscal 2025 earnings call. Today, I'm joined by Brian Tyler, our Chief Executive Officer; and Britt Vitalone, our Chief Financial Officer. Brian will lead off, followed by Britt, and then we'll move into the question-and-answer session.
Today's discussion will include forward-looking statements such as forecast about McKesson's operations and future results. Please refer to the cautionary statements in today's earnings release and presentation slides available on our website at investor.mckesson.com and to the Risk Factors section of our most recent annual and periodic SEC filings for more information concerning risk factors that could cause our actual results to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
